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Introduction
Smoking is seen as one of the most important 
preventable cause of morbidity and mortality throughout 
the world. It is responsible for more than 10% of deaths 
over the world and it has been predicted that it will account 
for more than eight million deaths in 2030, which 83% of 
them will occur in low-middle income countries (LMICs) 
(Mathers and Loncar 2006; Pinto and Ugá 2011; Arrieta 
et al., 2015; Jalilian et al., 2015). The negative economic 
impact of smoking on the health system and society 
as a whole is substantial (Jha and Chaloupka, 2000, 
Rezaei et al., 2015). It was reported that the smoking 
was responsible for 6 to 15% of national health care 
expenditure in high-income countries, 2.1%-3.4% of gross 
domestic product (GDP) in Australia, 1.3%-2.2% of GDP 
in Canada and 1.4%-1.6% of GDP in the United States 
(Jha and Chaloupka 2000, Allender, Balakrishnan et al., 
2009). However, the evidences concerning this issue are 
rarely documented in developing countries like Iran. The 
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Abstract
 Background: Smoking is recognized as a main leading preventable cause of mortality and morbidity 
worldwide. It is responsible for a considerable financial burden both on the health system and in society. This 
study aimed to examine the effect of smoking on cost of hospitalization and length of stay (LoS) among patients 
with lung cancer in Iran in 2014. Materials and Methods: A total of 415 patients were included in the study. 
Data on age, sex, insurance status, type of hospitals, type of insurance, geographic local, length of stay and cost 
of hospitalization was extracted by medical records and smoking status was obtained from a telephone survey. 
To compare cost of hospitalization and LoS for different smoking groups, current smokers, former smokers, and 
never smokers, a gamma regression model and zero-truncated poisson regression were used, respectively. Results: 
Compared with never smokers, current and former smokers showed a 48% and 35% increase in hospitalization 
costs, respectively. Also, hospital LoS for current and former smokers was 72% and 31% higher than for never 
smokers, respectively. Conclusions: Our study indicated that cigarette smoking imposes a significant financial 
burden on hospitals in Iran. It is, however, recommended that more research should be done to implement and 
evaluate hospital based smoking cessation interventions to better increase cessation rates in these settings. 
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epidemiological evidence indicated that the smoking is 
closely associated with around 50 diseases prominent 
among these are cardiovascular diseases, cancers and 
respiratory diseases (Mathers and Loncar, 2006; Pinto 
and Ugá, 2011). One of the main cancers related to the 
cigarette smoking is lung cancer (LC). LC is one of 
the five leading tumors in Iran, and the rate has been 
increasing steadily in both men and women (Hosseini et 
al., 2009, Khorasani et al., 2015). Based on GLOBOCAN 
database, a total of 4341 deaths due to LC (2950 in men 
and 1411 in women) in the Iran in 2012 (Ferlay et al., 
2014). Considering that more than 54% and 20.3% of 
these deaths are associated with smoking among men 
and women, respectively, in Iran (Rezaei et al., 2015). To 
our knowledge and based on literature review, sufficient 
information about effect of smoking on healthcare 
utilization and cost of hospitalization is not available for 
any diseases in Iran. The evidence concerning this issue 
is useful for health policy-decision making in Iran and 
other low-middle income countries (LMICs) in order to 
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reducing the smoking prevalence and implementation of 
successful smoking cessation interventions. This study 
aimed to address this gap in the literature and examine 
the affect smoking status on cost of hospitalization and 
hospital length of stay among patients with lung cancer 
in Iran in 2014.
Materials and Methods
Study Setting
Tehran is the capital of Iran and Tehran province, based 
on census 2011, with a population of around 9 million in 
the city and 16 million in the wider metropolitan area. 
Tehran is the largest city and urban area of Iran, the 
second largest city in Western Asia, and the 3rd largest in 
the Middle East. 
Study Sampling and Data Collection
In Iran’s health system network, inpatients care 
delivered through hospitals owned by different providers. 
Governmental hospitals trough the Ministry of Health and 
Medical Education (MOHME) is the main providers of 
inpatients services in Iran (68% of total hospital beds), 
followed by Private hospitals (12% of total hospital beds), 
Social Security Organization (SSO) of hospitals (9% of 
total hospital beds), Armed Forces hospital (4% of total 
hospitals beds). The rest of hospital beds was related to the 
Oil Company and NGOs (Hajizadeh and Nghiem 2013). 
In the study, the beds in these hospitals was considered 
to be governmental hospitals. All patients aged 34+ years 
discharged from these hospitals between 21 March 2014 
and 22 March 2015 who were diagnosed with lung cancer 
(ICD-10: C33-C34) were chosen as the study population. 
Because it is believed that the latent period between initial 
exposure smoking and occurrence cancer are about 20 
years and more (Kang et al., 2003, Rezaei et al., 2015).
In this study, samples were selected in two stage. 
First; 501 patients who were admitted between 21 
March 2014 and 22 March 2015 were selected based 
on hospitals beds in different providers (373 of patients 
in four governmental hospitals, 62 of patients from the 
two private hospitals, 45 of patients from the one Social 
security hospital and 22 of patients from the one Armed 
forces hospital). Data on sex, age, insurances status, type 
of diseases, local geographic, hospital length of stay and 
cost of hospitalization were retrieved from the patient’s 
medical records by self-constructed check list. In the next 
stage, the information about smoking status of the selected 
patients were obtained by telephone survey. Finally, based 
on response rate in telephone survey, 415 patients (307 
of patients in four governmental hospitals, 54 of patients 
from the two private hospitals, 36 of patients from the 
one Social security hospital and 18 of patients from the 
one Armed forces hospital) were included in the analysis. 
Statistical Analysis
Patients were classified as current smokers if they 
smoked at least one cigarette per day at the time of the 
hospitalized, as never smokers if they had never smoked 
or less than 100 cigarettes in their lifetime, as former 
smokers if they had smoked regularly or occasionally in 
the past and before hospitalized. 
Cost of hospitalization 
To account for non -normality of cost data (Shapiro 
Wilk test (p<0.001). Kruskal-Wallis test was used to 
explore the existence of any significant difference in 
hospitalization cost among different groups. To consider 
the skewed distribution of costs, a generalised linear 
models with gamma and log-link was used to examine the 
association between cost of hospitalization and smoking 
status while controlling for age, sex, geographic local, 
type of hospital, hospital LoS and type of insurance. In the 
previous studies, this model has been used to be a good 
methods for healthcare costs (Diehr et al., 1999; Barber 
and Thompson, 2004; Wacker et al., 2013). Modified Park 
Test confirmed gamma distribution (p=0.33), as well as 
Pregibon Link-Test (p=0.63) and Pearson Correlation Test 
(p=0.29) confirmed the choice of the log link function. 
Because of age of population study was more than 35, 
the variable age minus 35 years were used as the offset 
variables. Cost data is presented in the original currency, 
Iranian Rial. (34500 IRR equals approximately US $1 in 
2014-2015).
Hospital length of stay 
The length of stay of hospital was defined from the 
date of admission and the date of discharge and was 
considered as dependent variable. The Chi-square test 
was used to explore the univariate association between 
LoS and explanatory variable included in the study. A 
zero-truncated poisson regression was used to examine 
the association between hospital LOS and smoking status 
while controlling for age, sex, geographic local, types of 
hospital and type of insurance. A p-value less than 0.05 
was considered to be statistically significant and all data 
analysis was done by Stata software version 12. 
Ethics
This study was approved by the ethics committee of 
the Deputy of Research, Tehran University of Medical 
Sciences (Code: IR.TUMS.REC.1394.659)
Results 
A total of 415 patients with a mean age of 61.2 ± 9.8 
years (ranged from 35 to 93) were included in the study. 
Men comprised 70.8% (n=294) of the all patients. The 
mean of LoS for all of the patients was 10.5 ± 7.9 days, 
for male and female was 10.7 ± 8.3 days and 10.01 ± 6.6 
days, respectively. 42.9% of all of the patients was current 
smokers, while 43.4% and 13.7% were never and former 
smokers, respectively. The mean cost of hospitalization 
for all of the patients was 39333700 ± 34692030 IRR, for 
male and female was 40686100 ± 38035930 and 36047700 
± 24584440 IRR, respectively.  
Cost of hospitalization and smoking status 
The average cost of hospitalization was 52470550 ± 
43329550 for current smokers, 38761850 ± 25870360 
IRR for former smoker and 26523890 ± 19519710 
IRR for never smokers. Univariate analysis based on 
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Kruskal-Wallis test indicate that there were a significant 
association between age, LoS, smoking status and type 
of hospitals with cost of hospitalization. The descriptive 
characteristics of patients included in the study based on 
cost of hospitalization are presented in Table 1.
Compared with never smokers, current and 
former smokers showed a 48% and 35% increase in 
hospitalization costs (p<0.0001), respectively. The results 
of glm with gamma distribution and log link function for 
hospitalization costs are presented in Table 2. 
Hospital length of stay was associated with higher 
hospitalization costs. The hospitalization cost for patients 
with hospital LoS between 5 and 8 days had 81% higher 
hospitalization costs than patients with hospital LoS 
less than 5 days. The average cost of hospitalization for 
private hospitals was 1.37 times higher than compared 
with governmental hospitals. 
Hospital length of stay and smoking status 
The average hospital LoS was 13.17 ± 9.46 days for 
current smokers, 10.15 ± 6.21 days for former smoker 
and 7.96 ± 5.44 days for never smokers. Univariate 
analysis based on chi-square test indicate that there were 
a significant association between age, smoking status, type 
of insurance and type of hospitals with hospital LoS. The 
descriptive characteristics of patients included in the study 
Table 1. Descriptive Characteristics of Patients Included in the Study Based on Cost of Hospitalization
Variable Total Hospitalization Cost (%) P-value*n (%) low middle high
Sex Male 294 (70.8) 97 (33) 100 (34) 97 (33)
Female 121 (29.2) 40 (33.1) 40 (33.1) 41 (33.8) 0.92
Age (year) 35-64 247 (59.5) 64 (25.9) 96 (38.9) 87 (35.2)
65 168 (40.5) 73 (43.4) 44 (26.2) 51 (30.4) 0.006
Less than 5 days 98 (23.6) 78 (79.6) 14 (14.3) 6 (6.1)
 Hospital length of stay 5-8 days 102 (24.6) 45 (44.1) 52 (50.1) 5 (4.9)
9-13 days 103 (24.8) 14 (13.6) 53 (51.5) 36 (35)
More than 14 days 112 (27) 0 (0) 21 (18.7) 91 (81.3) 0.0001
Never 180 (43.4) 30 (16.9) 67 (37.6) 81 (45.5)
Smoking Status Former 57 (13.7) 24 (42.1) 6 (10.5) 27 (47.4)
Current 178 (42.9) 83 (46.1) 67 (37.2) 30 (16.7) 0.0001
Governmental 307 (74) 111 (36.2) 90 (29.3) 106 (34.5)
Type of Hospital Armed Forces 18 (4.3) 12 (66.7) 2 (11.1) 4 (22.2)
Private 54 (13) 3 (5.6) 32 (59.3) 19 (35.2)
Social Security 36 (8.7) 11 (30.6) 16 (44.4) 9 (25) 0.005
MSIO1 150 (36.2) 51 (33) 50 (33.3) 49 (32.7)
Type of insurance SSIO2 167 (40.2) 61 (36.6) 50 (29.9) 56 (33.5)
AMIO3 24 (5.8) 10 (41.6) 7 (29.2) 7 (29.2)
Other 37 (8.9) 8 (21.7) 14 (37.8) 15 (40.5) 0.48
Geographic Local Noninsurance 37 (8.9) 7 (19) 19 (51.3) 11 (29.7)
Tehran 274 (66) 86 (31.4) 103 (37.6) 85 (31)
Other provinces 141 (34) 51 (36.2) 37 (26.2) 53 (37.6) 0.83
1Medical Services Insurance organization; 2Social Security Insurance organization; 3Armed Forces Insurance organization.
Table 2. Results of GLM with Gamma Distribution and Log Link Function for Hospitalization Cost
Variable Cost Ratio (95% Conf. Interval) P-value
Sex Male 1
Female 1.11 (0.94-1.30) 0.189
Age groups 65 1
35-64 1.09 (0.94-1.25) 0.224
Less than 5 days 1
Hospital length stay 5-8 days 1.84 (1.51- 2.24) <0.0001
9-13 days 2.96 (2.41-3.65) <0.0001
More than 14 days 4.70 (3.86- 5.73) <0.0001
Never 1
Smoking Status Former 1.35 (1.09- 1.66) 0.004
Current 1.48 (1.26- 1.74) <0.0001
Geographic Local Tehran 1
Other provinces 1.05 (0.90 – 1.23) 0.48
Governmental 1
Type of Hospital Armed Forces 1.22 (0.73- 2.05) 0.436
Private 1.37 (1.06 - 1.77) 0.016
Social Security 1.01 (0.79 – 1.30) 0.89
AMIO3 1
Type of insurance Noninsurance 0.99 (0.59 – 1.67) 0.996
SSIO2 1.20 (0.76 – 1.89) 0.427
MSIO1 1.25 (0.79 – 1.98) 0.795
Other 0.80 (0.47 – 1.33) 0.395
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based on hospital LoS are presented in Table 3.
The results of zero-truncated poisson regression 
about impact smoking status and others explanatory 
variables included in the study with hospital length of 
stay are shown in Table 4. The results indicated that the 
LoS for current and former smokers were 72% and 31% 
higher than compared to never smokers.  Also, based on 
adjusted model, the LoS for patients who hospitalized in 
the governmental, social security and private hospitals 
were 76, 94 and 53% higher than compared with patients 
who were admitted in armed forces hospitals. There 
was no significant association between sex and type of 
insurance with LoS.
Discussion
The main objective of the present study was to 
examine the effect of smoking status both on cost of 
hospitalization and hospital LoS among patients with 
lung cancer in a hospital-based study in Iran. Cost of 
hospitalization for current and former smokers were 48% 
and 35% higher, respectively, than compared with never 
smokers. Also, compared with never smokers, hospital 
LoS for current and former smokers were 72% and 31% 
higher, respectively. To our knowledge, little information 
on the effects of smoking on cost of healthcare, deaths 
from diseases and medical care utilization are rarely 
documented in Iran. However, this was the first study to 
analyse affect smoking status on cost of hospitalization 
and hospital LoS among patients with LC in Iran. These 
findings add to our existing knowledge of the detrimental 
effects of cigarette smoking and are relevant specifically 
to patients with lung cancer.  
Based on our empirical analysis indicated that cost 
of hospitalization and hospital LoS for current and 
former smokers were higher than compared with never 
smokers. These finding are in line with finding from 
studied conducted in Germany(Wacker, Holle et al., 
2013), United Stated (Kahende et al., 2009), Canada 
(Azagba et al., 2013) and in Japan (Izumi et al., 2001). 
A study conducted by Kahende et al. concluded that 
the current smokers were more likely to be hospitalized 
Table 4. Results of Zero-Truncated Poisson Regression for Patients Included in the Study
Variable Adjusted IRR(95% Conf. Interval) P-value
Sex Male 1
Female 1.13 (1.05 – 1.22) <0.0001
Age groups 65 1
35-64 1.004 (0.94 – 1.07) 0.894
Never 1
Smoking Status Former 1.31 (1.19 – 1.44) <0.0001
Current 1.72 (1.60 – 1.85) <0.0001
Local Geographic Tehran 1
Other provinces 1.21 (1.13 – 1.29) <0.0001
Armed Forces 1
Type of Hospital Governmental 1.75 (1.37 – 2.25) <0.0001
Private 1.94 (1.49 – 2.53) <0.0001
Social Security 1.53 (1.18 – 1.99) 0.001
AMIO1 1
Type of insurance Noninsurance 0.80 (0.64 – 1.00) 0.056
SSIO2 0.89 (0.73 – 1.08) 0.262
MSIO3 0.96 (0.79 – 1.16) 0.698
Other 0.95 (0.76 – 1.17) 0.645
Table 3. Descriptive Characteristics of Patients Included in the Study Based on Hospital LoS 
Variable Total (%) Hospital Length of Stay (%) P –value*<5 8-May 13-Sep >14
Sex Male 294 (70.8)  68 (23.1) 75 (25.5) 77 (26.2) 74 (25.2) 0.942
Female 121 (29.2) 30 (24.8) 27 (22.3) 26 (21.5) 38 (31.4)
Age group 35-64 247 (59.5) 50 (20.2) 54 (21.70 77 (31.2) 66 (26.7) 0.002
65+ 168 (40.5) 48 (28.6) 48 (28.6) 26 (15.5) 46 (27.4)
Smoking Status Never 180 (43.4) 57 (31.7) 56 (31.1) 36 (20) 31 (17.2) 0.0001
Former 57 (13.7) 11 (19.3) 16 (28) 12 (21) 18 (31.6)
Current 178 (42.9) 30 (16.8) 30 (16.8) 55 30.9) 63 (35.5)
Governmental 307 (74) 83 (27) 74 (24.1) 62 (20.2) 88 (28.7)
Type of Hospital Armed Forces 18 (4.3) 10 (55.6) 5 (27.8) 0 (0) 3 (16.7) 0.001
Private 54 (13) 0 (0) 10 (18.5) 31 (57.4) 13 (24)
Social Security 36 (8.7) 5 (13.9) 13 (36.1) 10 (27.8) 8 (22.2)
MSIO1 150 (36.2) 34 (22.7) 48 (32) 29 (19.3) 39 (26)
Type of insurance SSIO2 167 (40.2) 46 (27.5) 37 (22.2) 38 (22.7) 46 (27.5) 0.009
AMIO3 24 (5.8) 9 (37.5) 4 (16.7) 5 (20.8) 6 (25)
Other 37 (8.9) 5 (13.5) 9 (24.3) 14 (37.8) 9 (24.3)
Local Geographic Noninsurance 37 (8.9) 4 (10.8) 4 (10.8) 17 (45.9) 12 (32.4) 0.19
Tehran 274 (66) 64 (23.4) 67 (24.4) 76 (27.8) 67 (24.4)
Other 141 (34) 34 (24.1) 35 (24.8) 27 (19.1) 45 (31.9)
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than compared with never smokers. Their analysis also 
indicated that among those who had an outpatient visit in 
the past year, current smokers had 4 times outpatient visits 
than to never smokers (Kahende et al., 2009). Wacker et 
al. have examined that the effect of smoking status on total 
cost (direct and indirect) from 2006 and 2008 in Germany. 
Their study have shown that there is a positive impact of 
current and former smoking on the healthcare utilization 
and total costs. They also concluded that total annual costs 
for current and former smokers were more than 20% and 
35%, respectively, higher compared with never smokers 
(Wacker et al., 2013).
Also, a Study conducted by Bertakis et al. have showed 
that smoking has a positive significant impact on use 
of healthcare services, while health status, depression, 
and key socio-demographic variables were controlled 
(Bertakis and Azari 2006). Warner et al. also found that 
costs for current and former smokers were significantly 
higher compared to never smokers. They also concluded 
that the predicted monthly difference between current 
and never smokers was $ 400 whereas it was $ 273 for 
former smokers compared to never smokers (Warner et 
al., 2014). In our study, the difference between current and 
never smokers was 25946660 IR in cost of hospitalization, 
whereas it was 12237960 IR for former smokers compared 
to never smokers.
The differences hospital LoS was 5.21 days between 
current and never smokers, while it was 2.19 days former 
smokers compared to never smokers. This results are 
consistence with finding from studies conducted by Izumi 
et al. in Japan (Izumi et al., 2001) and Robbins et al. in 
USA (Robbins et al., 2000). Izumi et al have found that 
hospitalization rate for smokers (current plus former) 
was 26% in males and 22% in females higher than 
compared with never smokers. Robbins et al. concluded 
that hospitalization rate for current and former smokers 
were 30% and 20% higher, respectively, than compared 
to never smokers.
The results of the current study should be interpreted in 
light of some limitations. Firstly, the finding from the study 
based on hospitals from Tehran city, so the other studies 
must be conducted in other part of the country to increase 
the generalizability of results of this study. Second, we 
were unable to adjust for the effect of severity of illness 
among patients on cost of hospitalization and hospital 
LoS because of data for these factors were not available 
from the medical records patients. Thirds, total hospital 
costs do not reflect actual hospital cost of smoking due to 
not including governmental subsidies to hospital services 
and all out of pocket payments by the patients. Moreover, 
non-direct medical costs such as transportation and food 
costs and indirect costs associated with lost productivity 
due to disability and mortality are not included in the study. 
However, measuring these costs was beyond the scope of 
this study. Fourth, to obtain the smoking status of patients, 
the telephone survey was used and self-reported smoking 
status might be lead to under estimation of prevalence of 
current and former smoking.
In conclusion, the present study emphasizes the 
negative effect of smoking on cost of hospitalization and 
hospital LoS among patients with lung cancer. Based on 
our study, the current and former smokers were higher 
than cost of hospitalization and LoS compared to never 
smoker; indicating it is imposes a considerable burden 
on hospital, health system and society as a whole.  It is, 
however, recommended that more research should be 
done to implement and evaluate hospital based smoking 
cessation interventions to better increase cessation rates 
in these settings. 
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